Paolo Rusconi

ORCID: 0000-0001-9767-1748
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Transplantation: Methods and Outcomes
  • Cardiomyopathy and Myosin Studies
  • Congenital Heart Disease Studies
  • Mechanical Circulatory Support Devices
  • Cardiovascular Function and Risk Factors
  • Diverse academic and cultural studies
  • Cardiac Structural Anomalies and Repair
  • Heart Failure Treatment and Management
  • Viral Infections and Immunology Research
  • Renal Transplantation Outcomes and Treatments
  • Italian Literature and Culture
  • Cardiovascular Effects of Exercise
  • Cardiac Arrhythmias and Treatments
  • Italian Fascism and Post-war Society
  • Cardiac pacing and defibrillation studies
  • Historical and Environmental Studies
  • Congenital heart defects research
  • Cardiac Valve Diseases and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Adenosine and Purinergic Signaling
  • Pulmonary Hypertension Research and Treatments
  • Urban Planning and Landscape Design
  • Renaissance Literature and Culture
  • Medieval European Literature and History
  • Architecture, Modernity, and Design

Jackson Memorial Hospital
2008-2025

University of Miami
2012-2024

University of Milan
2014-2022

Miami Transplant Institute
2020

Wayne State University
2017-2018

Children's Hospital of Michigan
2017-2018

Cincinnati Children's Hospital Medical Center
2011-2017

Le Bonheur Children's Hospital
2017

Boston Children's Hospital
2017

Creative Commons
2016

Restrictive cardiomyopathy (RCM) has been associated with poor prognosis in childhood. The goal of the present analysis was to use Pediatric Cardiomyopathy Registry analyze outcomes childhood RCM, a focus on impact phenotype comparing pure RCM cases that have additional features hypertrophic (HCM).We analyzed database (1990-2008; N=3375) for RCM. Cases were defined as when only assigned diagnosis. Additional documentation HCM at any time used criterion RCM/HCM phenotype. accounted 4.5%...

10.1161/circulationaha.112.104638 article EN Circulation 2012-07-28

Myocarditis is a cause of new-onset dilated cardiomyopathy phenotype in children, with small studies reporting high rates recovery left ventricular (LV) function.The presenting characteristics and outcomes children myocarditis diagnosed clinically biopsy confirmation (n=119) or probable by alone (n=253) were compared idiopathic (n=1123). Characteristics at presentation assessed as possible predictors outcomes. The distributions time to death, transplantation, echocardiographic normalization...

10.1161/circheartfailure.109.902833 article EN Circulation Heart Failure 2010-09-11

Pediatric dilated cardiomyopathy (DCM) is the leading indication for heart transplantation after 1 year of age. Risk factors by etiology at clinical presentation have not been determined separately death and in population-based studies. Competing risks analysis may inform patient prioritization listing.The Cardiomyopathy Registry enrolled 1731 children diagnosed with DCM from 1990 to 2007. Etiologic, demographic, echocardiographic data collected diagnosis were analyzed competing methods...

10.1161/circulationaha.110.973826 article EN Circulation 2011-07-26

Background Pediatric cardiomyopathy is a genetically heterogeneous disease with substantial morbidity and mortality. Current guidelines recommend genetic testing in children hypertrophic, dilated, or restrictive cardiomyopathy, but practice variations exist. Robust data on clinical practices diagnostic yield are lacking. This study aimed to identify the causes of investigate practices. Methods Results Children familial idiopathic were enrolled from 14 institutions North America. Probands...

10.1161/jaha.120.017731 article EN cc-by-nc-nd Journal of the American Heart Association 2021-04-28

Research comparing the survival of children with familial dilated cardiomyopathy (FDCM) to that idiopathic (IDCM) has produced conflicting results.We analyzed data from FDCM or IDCM using National Heart, Lung, and Blood Institute-funded Pediatric Cardiomyopathy Registry. Compared (n=647), (n=223) were older (mean 6.2 versus 4.5 years, P<0.001), less often had heart failure (64% 78%, less-depressed mean left ventricular fractional shortening z scores (-7.85±3.98 -9.06±3.89, P<0.001) lower...

10.1161/circheartfailure.115.002637 article EN Circulation Heart Failure 2017-02-01

RASopathies are a clinically heterogeneous group of conditions caused by mutations in 1 16 proteins the RAS-mitogen activated protein kinase (RAS-MAPK) pathway. Recently, RIT1 were identified as novel cause for Noonan syndrome. Here we provide additional functional evidence causal role and expand associated phenotypic spectrum. We two de novo missense variants p.Met90Ile p.Ala57Gly. Both resulted increased MEK-ERK signaling compared to wild-type, underscoring gain-of-function primary...

10.1111/cge.12608 article EN Clinical Genetics 2015-05-09

ABSTRACT Background Short‐term outcomes following heart transplantation in children have improved, but comparable improvements long‐term survival continues to barriers. We sought investigate and identify protective risk factors associated with children. Methods The Pediatric Heart Transplant Society (PHTS) database was queried for transplant recipients from 1993 2010 who were ≤ 10 years of age at time transplant. Patients conditional graft &gt; 3 ≥ analyzed. Survival time‐to‐event compared...

10.1111/petr.70042 article EN Pediatric Transplantation 2025-02-03

p53 influences genomic stability, apoptosis, autophagy, response to stress, and DNA damage. New p53-target genes could elucidate mechanisms through which controls cell integrity damage.DRAGO (drug-activated gene overexpressed, KIAA0247) was characterized by bioinformatics methods as well real-time polymerase chain reaction, chromatin immunoprecipitation luciferase assays, time-lapse microscopy, viability assays. Transgenic mice (94 p53(-/-) 107 p53(+/-) on a C57BL/6J background) were used...

10.1093/jnci/dju053 article EN JNCI Journal of the National Cancer Institute 2014-03-20

Abstract We aimed to determine whether malignancy after pediatric HT x for ACM affects overall post‐ survival. Patients &lt;18y listed in the PHTS database between 1993 and 2014 were compared those with DCM . A 2:1 matched cohort was also compared. Wait‐list survival, along freedom from common complications, Eighty subjects due , whereas 1985 Although wait‐list survival higher group, lower cohort. Neither difference persisted analysis. Primary cause of death group infection, which than...

10.1111/petr.12923 article EN Pediatric Transplantation 2017-04-04

Abstract: Hypertrophic obstructive cardiomyopathy (HOCM) associated with the use of tacrolimus is a rare complication liver and intestinal transplantation seen almost exclusively among pediatric patients. Reduction dosage or conversion to cyclosporin A (CsA) has been used as an effective treatment in reviewed cases. We present three transplant recipients who developed hypertrophic while under immunosuppression were treated sirolimus (Rapamycin ® ). The patients (ages 6 yr, 12 yr 11 months)...

10.1034/j.1399-3046.2000.00083.x article EN Pediatric Transplantation 2000-02-01

Danon disease is a rare entity associated with the clinical triad of mental retardation, skeletal myopathy, and severe hypertrophic cardiomyopathy. We report two cases describe results cardiac magnetic resonance imaging studies that were conducted to assess pattern hypertrophy.

10.1017/s1047951111000564 article EN Cardiology in the Young 2011-05-19
Lynn A. Sleeper Jeffrey A. Towbin Steven D. Colan Daphne T. Hsu E. John Orav and 90 more Matthew S. Lemler Sarah K. Clunie Jane Messere Darlene Fountain Tracie L. Miller James D. Wilkinson Steven E. Lipshultz Steven E. Lipshultz Michelle A. Grenier Amy Giantris Lina Rossetti Rachel Rossetti Kristina McCoy Mabel Meloche William F. Sullivan Eran Muto Kristen Lewis Renee L. Kursel O’Brien Michael Gurell Christy Cianfrini Marcie Keesler Melissa A. McDonald Steven E. Lipshultz James D. Wilkinson Paolo Rusconi Danielle D. Dauphin Jorge A. Alvarez Jason Czachor J. Álvarez Lynn A. Sleeper Lisa Cafferata Kirsten Noonan April M. Lowe Minmin Lü Rebecca Orfaly Linda Gilroy Foss Tighe Patti Arsenault Neena Pophali Lisa Schiavoni Stavroula K. Osganian Leigha Cuniberti Tara McKee Elizabeth Rauch E. John Orav Paul R. Lurie Steven E. Lipshultz James D. Wilkinson Dolores Tamer Grace Wolfe Paolo Rusconi Samuel S. Gidding Elfriede Pahl Sherrie Rodgers Steven D. Colan Gerald F. Cox Jane Messere Charles E. Canter Vernat Exil Arnold W. Strauss Daphne T. Hsu Carl N. Steeg Steven E. Lipshultz Michelle A. Grenier Carol J. Buzzard Susie C. Truesdell Mary Ann Rees David Wilk Seema Shaikh Daphne T. Hsu Darlene Fountain Rosalind Korsin Linda J. Addonizio Shilpi Epstein Allison Hill-Edgar Beth D. Kaufman M. Chrisant Joseph Rossano Stephen Webber Jeffrey A. Towbin Sarah K. Clunie John L. Jefferies Matthew S. Lemler Hollie Carron David E. Fixler Melanie D. Everitt Robert E. Shaddy Paul F. Kantor Lee Benson Alice Newman

10.1016/j.jpeds.2015.10.004 article EN The Journal of Pediatrics 2015-12-22
Coming Soon ...